GCNT3-mediated glycosylation in cancer biology: Implications for tumorigenesis, metastasis, and therapeutic targeting

  • 0Institute of Synthetic Biology Industry, Hunan University of Arts and Science, Changde 415000, China.

Summary

This summary is machine-generated.

Core 2 β-1,6-N-acetylglucosaminyltransferase 3 (GCNT3) impacts cancer progression differently across tumor types. Understanding its dual role is key for developing targeted cancer therapies and biomarkers.

Area Of Science

  • Biochemistry
  • Cancer Biology
  • Glycobiology

Background

  • Glycosylation is a critical post-translational modification influencing cancer hallmarks.
  • Core 2 β-1,6-N-acetylglucosaminyltransferase 3 (GCNT3) is a key glycosyltransferase implicated in tumor progression.

Purpose Of The Study

  • To review the multifaceted roles of GCNT3 in various cancers.
  • To explore GCNT3's potential as a prognostic biomarker and therapeutic target.

Main Methods

  • Literature review of studies investigating GCNT3 expression and function in cancer.
  • Analysis of GCNT3's impact on cell adhesion, metastasis, immune evasion, and drug resistance.
  • Evaluation of GCNT3's clinical relevance in different cancer types.

Main Results

  • GCNT3 exhibits dichotomous effects: promoting better outcomes in ovarian cancer but worse in pancreatic and lung cancers.
  • GCNT3 shows promise as a biomarker for prognosis and treatment response, especially in colorectal and ovarian cancers.
  • Therapeutic targeting of GCNT3 faces challenges due to its physiological roles and lack of selective inhibitors.

Conclusions

  • GCNT3's complex and cancer-specific functions necessitate tailored therapeutic strategies.
  • Combination therapies involving GCNT3 modulation may enhance treatment efficacy.
  • Further research into selective GCNT3 inhibitors and cancer-specific approaches is crucial for clinical translation.

Related Concept Videos

mTOR Signaling and Cancer Progression 03:03

3.8K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Protein Glycosylation 01:25

6.8K

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...

Mitogens and the Cell Cycle 02:38

6.4K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Metastasis 02:30

5.5K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Cancer-Critical Genes I: Proto-oncogenes 01:33

8.7K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Non-Canonical Wnt Signaling Pathways 01:41

7.3K

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...